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Abstract
A macro model of morbidity and mortality in children under five
years of age is presented.  Monthly disease-specific incidence
and case fatality rates form the basis of the model and the
efficacy and coverage of disease-specific interventions alter
these values.  In addition, frailty is modeled via relative risks
of mortality based on five groups, determined in the first month
by the birthweight distribution and at later ages by the
proportion of children surviving a given illness who become more
frail and the proportion not ill and with adequate nutrition who
become less frail.  A validation of the model was carried out
using data from the comparison and treatment areas of the
Demographic Surveillance System in Matlab, Bangladesh.  The model
very closely predicts the observed mortality level.  Scenarios
for improvements in coverage of specific interventions in
settings in South Asia, West Africa and Andean South America are
modeled and their effects on mortality gauged.  The model
provides a useful tool for those wishing to know the mortality
impact of specified mixes of interventions in a given setting. 
Limitations of the model are considered and possible extensions
to address these are discussed.
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Infant and child mortality in many developing nations are very
high due to frequent infectious diseases such as pneumonia and
diarrhea (UNICEF, 1992).  These deaths can be averted by
interventions to prevent or treat the disease.  For example,
breastfeeding and clean water can help prevent diarrhea, while
oral rehydration therapy (ORT) can reduce deaths among those who
have diarrhea.  Preventive interventions are usually broad-based
at the community level, since all children must be covered, while
curative interventions are applied to children with specific
diseases.
The impact of any intervention depends upon the disease (or
diseases) affected, the frequency of the disease(s) in the
population, and the efficacy and coverage of the intervention. 
Preventive measures may have a greater impact on mortality than
curative measures if they prevent multiple diseases.  An example
is vitamin A supplementation, which has been shown to protect
children against death from multiple infectious diseases (Sommer
1986, Beaton et al. 1992).  With respect to curative
interventions, although their clinical efficacy may be known, it
is unclear how much they can reduce mortality in a given
community setting for two reasons--competing causes of death and
frailty.  For example, antibiotics can prevent a pneumonia death,
but a child saved from pneumonia may succumb to a later episode
7
of diarrhea.  Additionally, the pneumonia episode may have
brought about reduced food intake leading to a decreased
nutritional status (increased frailty), which puts the child at
greater risk of mortality from subsequent infectious diseases.
A morbidity-mortality model that incorporated incidence, case
fatality, interventions (and their associated costs), disease
combinations, and competing risks was proposed by Barnum et al.
(1980).  An intended use of the model was to aid policymakers in
finding cost-effective interventions.  However, the model had
several limitations.  It relied heavily on subjective evaluations
of the impact of interventions since empirical estimates of these
were limited at the time that the model was developed.  Also, it
did not incorporate frailty.  Furthermore, the model was complex
and the computer software not generally available or easy to use.
Another model that included incidence, case fatality, frailty and
competing risks, but not efficacy and coverage of interventions
was presented by Mosley and Becker (1991).  In addition, any
attempt to determine mortality trends in the 1990's needs to
consider the effect of AIDS.  Thus, to reasonably predict the
impact of various health intervention strategies on infant and
child mortality in developing nations, it was necessary to
develop a new model.
THE MODEL
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A macro-model of child mortality was designed to incorporate the
following elements: disease-specific incidence and case fatality,
frailty of children affecting the level of case fatality, with
the frailty distribution of children at birth defined by the
birthweight distribution, and frailty at later ages affected by
cumulative disease insults and by the presence or absence of
adequate nutrition or nutritional interventions; and health
interventions to lower incidence and/or case fatality of selected
diseases, with parameters for both efficacy and coverage of the
interventions.  Table 1 gives details of the diseases in the
model and the interventions.  In neonates, the specific causes of
death are: 1) tetanus, 2) sepsis and pneumonia, 3) birth trauma
and asphyxia, 4) diarrhea, 5) AIDS, and 6) all other causes.  In
those above one month of age, the causes are: 1) diarrhea, 2)
respiratory disease (largely pneumonia), 3) malaria, 4) measles,
5) AIDS, and 6) other.  Case fatalities due to AIDS and "other
causes" are unaffected by frailty.
TABLE 1 ABOUT HERE
Figure 1 gives the flow of the model.  The birth cohort starts
with a given birthweight distribution, which can be modified in
the model by nutritional interventions among mothers.  Five
frailty groups are defined with different relative risks of
death .  Age-specific disease incidence and case fatality in the1
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population are then adjusted by the efficacy and level of
coverage of the interventions.  Children who become ill are then
subjected to the case fatality rate multiplied by the relative
risk of death according to their frailty group.  Children who
survive the illness become more frail with a certain probability
which depends on the illness; otherwise they remain in the same
frailty group.  A proportion of all surviving children are then
shifted to a less frail group according to the proportion of
children receiving an adequate diet and coverage of vitamin A
supplementation.  Surviving children enter the next age group and
the process is repeated.  The age interval for the model is a
single month so the process is repeated sixty times.  The one
month interval was chosen in part to minimize the problem of
multiple concurrent diseases.  The latter are ignored by the
model becasue the number of possible combinations of illnesses
and the coverage and efficacy of interventions for them is very
large and unwieldy.
FIGURE 1 ABOUT HERE
The proportion of newborns infected with HIV is determined by
multiplying the prevalence in pregnant women by the probability
of transmission to the newborn.  Children with HIV are treated
separately; they have a certain risk of dying of AIDS and are
exposed to the same incidence and case fatality of other diseases
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as other children.  All of the children with HIV infection are
assumed to die by age five (i.e. case fatality = 1.0 by the last
age group).
After preparation of a flow chart, a specialized computer program
was written in the FORTRAN language to perform the calculations,
which simply involve addition and multiplication of the numerical
input parameters. Appendix 1 gives the key equations.  To check
the results, a second programmer independently wrote a program in
the C language.  Outputs were compared and several minor
programming errors were found in each program and corrected.
The main outputs of the model are age-cause-specific
probabilities of death (q ). Though estimates for single monthsx
of age are available, for most purposes the following age groups
are considered: neonates, post-neonates, 12-23 months, 24-35
months, 36-47 months, 48-59 months.  For infants, traditional
neonatal and post-neonatal death rates are calculated using
births as the denominator.  For other age groups, cause-specific
probabilities of death are calculated using the initial
population in the age group as the denominator.  We use the term
mortality to refer to these probabilities.  Sexes are combined.
Developing Country Settings Examined
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Models were constructed for three developing country settings
utilizing the best available information for each setting. The
three were: A West African setting with high mortality and a high
prevalence of malaria infection; a South Asian setting with high
mortality and low prevalence of malaria; and an Andean South
American setting with a moderately high level of mortality and a
low prevalence of malaria.  These settings are intended to be
national in scale, but do not represent specific countries. 
Nevertheless, the availability of useful information from some
countries, e.g. The Gambia (Greenwood et al. 1987a, 1987b) and
Nigeria (Federal Office of Statistics, 1992) in West Africa,
Bangladesh (Fauveau, 1994) in South Asia, and Peru (INEI, 1992)
and Bolivia (Sommerfelt et al. 1991) in South America, allowed
the model to be based largely on recently collected information
concerning incidence and case fatality rates and the coverage of
health and nutritional interventions.  On the other hand, the
efficacy inputs for the various interventions were generally
based on the best evidence from developing countries as a whole.
For most of the diseases considered, it is difficult to determine
the natural incidence in the absence of interventions such as
good water, sanitation, breastfeeding, or good delivery
practices.  Therefore, information on the current incidence of
diseases such as diarrhea, pneumonia, neonatal tetanus, or birth
trauma/asphyxia, was used, along with the current coverage and
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efficacy of interventions, to extrapolate back to the "natural"
incidence in the complete absence of interventions.  This
incidence was then utilized as a starting point in the model.
(See Appendix 1.)  For malaria, a similar approach was used. The
model treats the inputs as incidence, although the results might
better be interpreted as reflective of the prevalence of malaria
infection.  We return to this point in the discussion.  
Disease and Intervention Inputs in the Model 
The incidence and case fatality rates for neonatal causes of
death in the three settings are given in Table 2 as are the
coverage of relevant interventions.  The efficacies of
interventions, assumed constant for all age groups and all
settings, are given in Table 3.  Table 4 shows the initial
frailty groups defined by the birthweight distributions in the
three settings, and the associated relative risks of mortality. 
Table 5 gives the estimated percentage of all children becoming
more frail with a given disease and the percentage becoming less
frail with a given intervention.
TABLE 2, 3 and 4 ABOUT HERE
For neonatal tetanus, the case fatality rate was set at 85%.  All
survivors become more frail.  The interventions against neonatal
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tetanus examined were two doses of tetanus toxoid during
pregnancy, considered to have an efficacy of 80%, and good
delivery practices with an efficacy of 50% (Schofield 1986).
Given the limited resources in most developing country settings,
an intervention to reduce case fatality from neonatal tetanus was
not considered.
Neonatal deaths from birth injury, asphyxia, and other
potentially preventable birth-related causes were grouped
together (Partinidhi et al 1986, Shah 1990).  Children surviving
these conditions in the first month of life were considered to
have a probability of shifting to a more frail group of 0.8
(Table 5).  The intervention to prevent deaths in this group was
good delivery practices, considered to have an efficacy of 50%. 
TABLE 5 ABOUT HERE
For neonatal respiratory disease, the case fatality rate was set
between 13% and 30% depending on the setting, with the higher
rate in South America.  For children surviving these conditions,
the probability of becoming more frail is 0.3.  The intervention
for these conditions is antibiotic therapy, with an efficacy of
50%.
After the first month of life, the incidence of pneumonia was
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estimated for each month of age  from the best available
community-based studies (Selwyn, 1990; Oyejide and Osinusi, 1990;
Stewart, de Francisco and Fauveau, 1993). The incidence is
highest in the youngest children  and falls progressively with
age.
With regard to interventions, breastfeeding is considered to
protect against pneumonia.  The efficacy of this protection was
estimated at 50% for children 0-5 months of age and 25%
thereafter (Victora, personal communication). Case management of
pneumonia with appropriate antibiotics is considered to reduce
the case fatality rate by 50% (Sazawal and Black, 1992).  
Diarrheal diseases were included from the neonatal period onward. 
The diarrheal incidence rates were determined from
community-based studies in the three settings (Black et al. 1982,
Black et al. 1989; Oyejide and Fagbami, 1988).  The rates
increase during the first twelve months of life to a peak level
between 12 and 17 months of age of 0.35 to 0.40 episodes per
month. The rates fall progressively thereafter to a low of 0.25
per month.  The case fatality rate is highest for diarrheal
episodes during the neonatal period and drops progressively
during the first year of life. 
Two preventive interventions for diarrhea and one therapeutic
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intervention were considered.  Clean water and good sanitation
together are considered to result in a 25% reduction of diarrhea
incidence (Esrey, Feachem and Hughes, 1985).  Breastfeeding
during the first six months of life was estimated to have a 60%
efficacy for prevention of diarrhea and a 25% efficacy after six
months (Feachem and Koblinsky, 1984).  For all diarrheal
diseases, ORT was considered to have an efficacy of 30% (Richards
et al. 1993).  This rather low efficacy for ORT is the result of
two factors.  First, ORT given in the home, rather than in health
facilities, may not be done optimally.  For example, if it is
given late or consumed in inadequate volumes, it may not prevent
or correct dehydration that could lead to death.  Second, ORT is
primarily of value for acute dehydrating diarrheas that are now
estimated to cause only 35-50% of all diarrhea-associated deaths
(International Study Group on Mortality Due to Diarrhea, 1993).
The remaining deaths, associated with dysentery or persistent
diarrhea, are not greatly benefitted by ORT (Chowdhury et al.
1991).  On the other hand, more comprehensive diarrheal
management, including antibiotics for dysentery and dietary
management of persistent diarrhea along with correctly used ORT,
would be substantially more efficacious for all diarrheas.  The
efficacy of such comprehensive diarrheal treatment was considered
to be 80%.
Malaria was considered to affect children after the neonatal
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period.  While the model incorporates incidence, the data
available are for prevalence of parasitemia by age and are better
regarded as such.  The case fatality rate (percentage of children
with parasitemia dying each month) was considered to be 1% in the
three settings. The case fatality rate was applied to each month
of age that a malaria infection was present.
The malaria interventions are treatment and prophylaxis.  The
decrease in the case fatality rate after presumptive treatment
with chloroquin was considered to be only 20%.  The efficacy is
low because much of the presumptive self-treatment of fever with
chloroquin is of questionable appropriateness and because of drug
resistance to chloroquin (Greenwood et al 1988, World Health
Organization 1990).  The use of prophylactic chloroquin in
children is infrequent (Institute of Medicine, 1991).  In the
model the presumptive treatment of fever with chloroquin was also
considered like prophylaxis to reduce the incidence of infection
with an efficacy of 50%.  Thus, presumptive treatment had an
effect on both the case fatality rate and on incidence.  
The expected incidence of measles in the absence of measles
vaccination was estimated from community-based studies (Dave
1983, McLean and Anderson 1988) and was assumed the same in all
three settings.  The incidence increases gradually from three to
twelve months of age, reaching 3% per month, and then declines
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after 23 months of age.  These incidence values would result in
85% of children having measles before their fifth birthday.  The
case fatality rate was fixed at 2% in South Asia and South
America and 4% in West Africa (Grabowsky et al. undated). 
Survivors from measles were also considered to have possible
complications; the rate of diarrheal complications was estimated
to be 30% and of pneumonia 10%.  These complications had the same
age-specific case fatality rates as for those diseases without
measles.
The interventions for measles include both measles vaccine to
reduce the incidence and therapy that could reduce the case
fatality rate.  With regard to the complications, the efficacy
and coverage of ORT (or comprehensive diarrhea management) were
assumed for treatment of the diarrhea associated with measles,
and antibiotic efficacy and coverage were used for treatment of
the pneumonia.  In addition, vitamin A was considered to have an
overall effect on measles case fatality with a 30% efficacy. 
(Hussey and Klein, 1990). 
Other causes of death, including injuries, were considered as a
group and were treated differently for the newborn period and
subsequent periods.  During the neonatal period, since there is a
substantial amount of mortality associated with congenital
abnormalities and other non-preventable conditions, mortality due
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to other causes was estimated at five per 1000 in all settings. 
For AIDS mortality, the proportion of pregnant women infected
with HIV around 1990 was used (Preble 1990, Anderson and May
1992, Quinn et al. 1992).  This was estimated to be 0.001 for
South Asia and South America and .02 for West Africa.  To
determine the proportion of newborns developing HIV infection,
this figure was multiplied by 0.3 for the apparent rate of
transmission during pregnancy, childbirth or breastfeeding
(Preble 1990).   No intervention was considered for AIDS and all
births with HIV were assumed to die by age five years.
Frailty Distribution and Frailty Factors
The initial frailty groups (Table 4) were determined utilizing
the distribution of birthweights in each setting (World Health
Organization 1984).  Subsequent frailty groups were derived from
the contribution of infectious diseases to increasing frailty and
the effect of adequate diet or vitamin A supplementation in
reducing frailty.  The relative risks of death associated with
the five frailty groups are 0.5, 1.0, 3.0, 5.0 and 10.0 (Victoria
et al. 1988; Ashworth and Feachem, 1985; Pelletier, Frongillo and
Habicht, 1993).  For each disease, the proportions of children
getting more frail due to the disease (Table 5) were estimated
from studies evaluating the effect of these infections on
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nutritional status (Black, Brown and Becker, 1984; Becker, Black
and Brown, 1991).  In the model, a child could change only one
frailty group up or down in a month.   The sensitivity of the
results to the values of these fraility parameters is examined
further below.  
The interventions that could move children to a less frail group
were adequate nutrition and vitamin A supplementation.  Adequate
nutrition was considered to be a composite of optimal energy
intake, protein source (animal), and micronutrient intake
appropriate for each age group.  Children receiving at least the
FAO/WHO requirements for age were considered to have adequate
nutrition (WHO, 1985).   For children with adequate nutrition, we 
estimated that 10% would switch to a less frail group in each
month in the absence of a serious infectious disease.  For
vitamin A, the receipt of routine supplementation was considered
sufficient to result in 10% of children switching to a less frail
group each month.  Children already receiving adequate nutrition
were considered to have adequate vitamin A intake.  Therefore,
vitamin A supplementation had an effect on frailty only in
children not receiving adequate nutrition.  
Validation of the model
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One might well ask to what extent the model gives a good
approximation to reality.  The inputs for the model are numerous,
some estimates are known with poor precision and values of other
parameters are virtually unknown (e.g. frailty factors) so it is
important to assess the validity of the model in some way.
The extensive data available from the Demographic Surveillance
System (DSS) in Matlab, Bangladesh provide an excellent
opportunity for such a validation.  In the Matlab area a rural
population of 200,000 has been included in a vital registration
system for more than twenty years.  In 1978 the registration area
was divided for program purposes into "treatment" and
"comparison" areas with specific maternal and child health
interventions added in the former area (Bhatia, Mosley and
Faruque, 1980).  In addition to vital registration data on births
and deaths, data have also been collected on use of specific
health interventions (Fauveau, 1994).
The procedure for validating the model with these data was as
follows:  First, estimates of input values for incidence and case
fatality due to specific causes were derived for the comparison
area for the period 1987-1990.  Data on age-specific levels of
intervention coverage were also available for that period (Table
6).  These were entered in the model and are described more fully
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in Appendix 2.  The resulting outputs of infant and under-five
mortality and the distribution by cause of death were compared to
the actual values of these from the vital registration reports
(ICDDR,B 1992, 1993 and 1994) for those years ; the incidence and2
case fatality inputs were then adjusted until the observed and
model mortality levels were virtually identical.  These were used
to generate the South Asian model.  
TABLE 6 ABOUT HERE
Next the coverage levels of interventions were estimated from
data for the "treatment" (health service intervention) area in
Matlab (Table 6).  These were entered in the model and all other
parameters were the same as in the comparison area.  The
resulting mortality and cause of death distributions were
compared with the observed values of these from the DSS data. 
Large differences between the predicted mortality and observed
levels in the treatment area would show that the model was not
valid; small differences would indicate that the model can
produce valid results, at least for this setting. 
Values of efficacies of interventions are those derived in the
previous section and were identical in the two areas.  Table 6
gives the age-averaged coverage of relevant interventions that
varied between the two areas.  For the comparison area the model
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was calibrated to produce the observed levels of infant and
under-five mortality of 92.5 and 135.5 deaths per 1000
respectively.  The comparison of cause of death distributions is
given in Table 7.  
TABLE 7 ABOUT HERE
The changes in coverage of interventions to those of the
treatment area produced output infant and under-five mortality
levels of 78 and 106 per 1000 respectively.  The actual values of
these measures for the treatment area from published DSS reports
were 77 and 103 per 1000 respectively.  Thus, the model results
were less than 3% different than the actual values.  Note that
the registered infant and under-five mortality levels were 16%
and 22% lower in the treatment area than in the comparison area. 
We conclude that the present model can quite accurately reflect a
real world situation. 
Sensitivity Analyses
We did sensitivity analyses to determine to what extent the
results are affected by the frailty parameters and changes in
them.  With the basic parameters in the South Asian model held
fixed, we made the following changes in frailty: 1) Frailty was
deleted from the model by setting all relative risks to 1.0; 2)
The relative risks associated with the frailty groups were
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alterred to decrease the effect of frailty.  Specifically,
relative risks for the five groups were set at  .75, 1.0, 2.0,
3.0 and 5.0 instead of .5, 1.0, 3.0, 5.0 and 10.0; 3) Relative to
baseline levels, the proportions of children getting more frail
with each disease were increased and decreased in separate runs
by 25%;  4) The proportions of children getting less frail with
adequate nutrition were increased and decreased in separate runs
by 25% 
With frailty eliminated, the model gives an estimate of under-
five mortality that is 26% below the estimate with frailty
included (Table 8).  In the same vein, when the relative risks
are brought closer to 1.0, mortality is also decreased. 
When the proportions getting more frail due to diseases are
changed by 25%, mortality changes by only 3%.  On the other hand,
when the proportions getting less frail due to adequate nutrition
or vitamin A supplementation are changed by 25%, the results for
mortality are 5% to 6% different from baseline levels.  These
larger changes in mortality compared to those when frailty
parameters associated with disease were changed by the same
percentage, occur because the nutritional effects apply to all
children while the disease-specific frailty factors only apply to
sick children.  We conclude that frailty contributes
significantly to mortality in the  model but that the estimates
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of mortality are relatively insensitive to errors in
specification of the frailty parameters associated with diseases
and nutrition.
TABLE 8 ABOUT HERE
MODELING SCENARIOS OF HEALTH INTERVENTIONS
Eleven intervention scenarios were evaluated for their effect on
under-five mortality ( q ); changes were made in the intervention5 0
efficacies and/or coverages fixing other parameters at their
baseline levels for the three settings. 
 
The World Summit for Children in 1990 established a list of goals
for the year 2000 (UNICEF, 1991).  These included reduction of
overall under-five death rates by one third, reduction of
diarrheal deaths by one half, and respiratory deaths by one
third, elimination of neonatal tetanus, and reduction in measles
deaths by 95%.  The Summit also established targets for
immunization coverage.  WHO and UNICEF have established service
delivery targets that they feel are achievable and should result
in mortality reductions commensurate with the Summit goals. 
These service delivery targets were utilized in the model to
estimate their effect on child mortality. To estimate the effect
of an increasing prevalence of HIV in adult women by the Year
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2000, the proportion of pregnant women infected was estimated at
0.01 for that year in South Asia and South America, up from the
baseline level of 0.001. In West Africa the proportion was
changed from .02 to .10.  Table 9 lists the eleven scenarios that
were studied with the model.  Mortality by age and cause was
estimated for each scenario and compared to the results of the
model using the baseline parameters in the three settings. 
 
TABLE 9 ABOUT HERE
The results of the various scenarios of health interventions are
given in Table 10.   In general because the levels of coverage of
interventions are initially higher in South America,
implementation of a given scenario has less absolute and relative
impact on mortality there than in West Africa and South Asia.  
In South Asia the greatest single impact on mortality occurs when 
measles immunization is increased to 90% (scenario 4).  In South
America and West Africa, by contrast, vitamin A supplementation
is predicted to have the greatest impact in reducing mortality
(scenario 6).  South Asia had less effect from vitamin A
supplementation since the current level of supplementary coverage
was considered to be 50%, whereas in the other two regions it was
zero.  Increasing good birthing practices to 80% and increasing
coverage of good sanitation have similar and small effects in
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South America and West Africa but increasing good birth practices
has a greater effect in South Asia (scenarios 9 and 10). 
In all three settings increasing ORT coverage to 80% alters
mortality levels only slightly (scenario 2).  This is due to the
assumed low efficacy of ORT against all diarrheas.   In all three
settings, having comprehensive diarrheal treatment reduces
mortality much more than increasing ORT coverage alone. 
Table 11 gives further detail; it shows the percentage declines
in cause-specific mortality in South Asia under the same
scenarios.  The effect of increasing tetanus toxoid from 20% to
90% is a 65% reduction in tetanus mortality (from 5.7 to 2.0 per 
1000.  Increasing measles vaccine coverage has a substantial
impact on deaths attributed to diarrhea as well as those
attributed to measles but it only has a minor effect on pneumonia
mortality.
With the inclusion of increased AIDS incidence, the declines in
mortality are reversed in West Africa as q  rises from 162 to5 0 
183 per 1000.  In South Asia and South America the inclusion of
AIDS changes mortality only slightly.
TABLES 10 AND 11 ABOUT HERE
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Non-additive effects of interventions
In the presence of competing risks of illness and death it is
clear that a given intervention will have an equal or greater
impact on mortality in the absence of other interventions, than
when other interventions are  present.  To explore this
quantitatively, we ran the South Asian model for the individual
components of scenarios in Table 9 and compared the difference
between the mortality level with only the given intervention and
the baseline mortality, with the difference between mortality
levels with the addition of each successive component as shown in
Table 10.   These estimates are compared in Figure 2.  The sum of3
the separate intervention effects would imply an overall under-
five mortality decline of 58 per 1000 (a 43% decline).  This is
contrasted with a decline of 50 per 1000 predicted by the model
with all the interventions introduced simultaneously.  From the
figure we see that the interventions on case fatality have
similar effects on mortality whether introduced singly or with
other interventions.  However, the interventions on disease
incidence (e.g. measles vaccine) and frailty (e.g. vitamin A)
show a much greater impact when introduced singly into a
population.  One difference is in the opposite direction--the
effect of increasing the efficacy of ORT from 30% to 80% in the
model with cumulative interventions is greater than when it is
introduced singly.  This is because greater ORT efficacy is a
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more potent intervention in combination with an increase in
coverage of ORT (from 57% to 80%).
FIGURE 2 ABOUT HERE
DISCUSSION
The quantitative effects of health interventions in reducing
total childhood mortality in developing nations are difficult to
estimate.  Recent studies have shown that vitamin A
supplementation can reduce mortality rates in children 6-59
months old by approximately 20% in settings with relatively high
mortality and vitamin A deficiency (Sommer et al. 1986; Beaton et
al., 1992). Measles vaccine has been shown to lead to a similar
level of reduction (Aaby et al. 1984; Clemens et al. 1988; Koenig
et al. 1991) and  it has been argued that ORT reduced overall
infant and child mortality by more than 30% in Egypt (El-Rafie et
al. 1990).  With multiple interventions and multiple causes of
death, the picture becomes complex, i.e. these separate effects
cannot be added.
International health agencies and policy makers must decide on
the interventions to emphasize in a given setting.  The World
Bank has recently outlined global health challenges (World Bank,
1993).  Before calculations of cost-effectiveness can be made for
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this purpose, models combining epidemiological and demographic
parameters must be constructed so the effects of various mixes
and levels of interventions in a given setting can be predicted. 
We have presented one such model in this paper.
The results from the model for South Asia clearly show that
fairly large increases in intervention coverage do not
necessarily lead to large decreases in mortality.  For example,
increasing ORT coverage from 57% to 80% in South Asia only drops
diarrheal mortality by 3 per 1000.  On the other hand, including
comprehensive diarrheal treatment drops the diarrheal specific
mortality 10 per 1000 from its initial level.  This is because
ORT alone only has 30% efficicay against diarrheal death while
comprehensive treatment has an 80% efficacy.
The child survival interventions have been selected for
widespread implementation because they address important causes
of child mortality and indeed ORT and immunization programs have
reduced mortality levels.  However, it must be kept in
perspective that these least costly interventions have
limitations.  Also there may be problems reaching children who
are at highest risk of mortality.
Furthermore, the reductions in mortality from a very restricted
set of interventions will be at best moderate in most settings,
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even if they are delivered optimally.  This speaks for the need
to implement a complementary set of preventive and therapeutic
interventions addressing the common causes of mortality in
children - diarrhea, measles, tetanus, malaria and pneumonia. 
Such a package of interventions implemented with potentially
achievable coverage levels could reduce child mortality by up to
40%, consistent with the UNICEF Summit targets.  Interventions
that reduce frailty should have substantial effects on mortality
from various causes (Pelletier, Frongillo and Habicht, 1993). 
For example, increasing vitamin A coverage in the model from 50%
to 80% decreases under-five mortality from 105 to 101 per 1000 in
South Asia and the effect is even more in other regions with
widespread deficiency and without supplementation programs. 
This macro-model is a useful tool to study the effects of various
interventions on child mortality. Of course, as in any such
exercise, the results are highly dependent on the inputs and
assumptions of the model.  The best available data were used as
inputs.  However, as noted above, some parameters are not
directly observable in the population, in particular the
proportion of children becoming more frail with a given disease
or less frail with nutritional interventions.   From the
sensitivity analyses we have shown that a 25% error in these
frailty parameters would yield no more than 6% error in
mortality.  This is relatively small compared to the overall
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effect of incorporating frailty in the model (i.e. a 26%
difference in estimated mortality between models with and without
frailty).
Generally, the model is very flexible in structure, allowing: a)
six disease groups; b) incidence, case fatality and coverage of
interventions that can vary with each month of age; c) explicit
frailty effects depending on each disease and d) the efficacy of
interventions that affect incidence or case fatality of diseases,
or frailty.  This permits the examination of a wide range of
interventions either singly or in combination, while accounting
for competing risks and frailty.  
However, in some ways the model is restrictive: a) Having five
frailty groups is arbitrary (although the number could quite
easily be changed) and frailty-specific relative risks of death
are assumed to be equal for all infectious diseases; b) Risks
associated with multiple concurrent illnesses are not included ;4
c) Malaria is incorporated via incidence and case fatality rather
than prevalence; d) Disease rates for children with HIV infection
are assumed to be the same as those in the general population; e)
The model presently assumes homogeneity although populations are
actually heterogeneous with respect to incidence and case
fatality of diseases and coverage of interventions  and f)5
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Variances of estimates are not available since it is a
macrosimulation rather than a microsimulation model. In addition,
cost-effectiveness cannot be examined directly since cost
estimates of interventions were not incorporated.  The model
could be further extended to remove most of these restrictions. 
Nevertheless, the present model can be very useful for providing
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 The number of groups was arbitrarily chosen.1
 The values from the reports were averaged.2
3 Malaria intervention was excluded from this analysis because it
had a trivial effect in South Asia and AIDS prevalence for the
year 2000 was excluded as well because it operates to increase
mortality.
4 Similarly, considering in a sequential manner the proportions
getting more frail from a given disease and then the proportion
getting less frail because of good nutrition, gives different
results than if these are considered simultaneously with the
joint probability of the four possible outcomes [i.e. 1) illness
makes the child more frail and this is not compensated by good
nutrition; 2) illness makes the child more frail and this is
compensated by good nutrition so the child stays in the same
frailty group; 3) illness does not make the child more frail and
good nutrition puts him/her in a less frail group; 4) illness
does not make the child more frail and the absence of good
nutrition means that he/she stays in the same frailty group.] 
Treating illness and nutrition interventions sequentially allowed
us to consider all children in  a frailty group (whether ill or
not) with respect to nutrition interventions since the
proportions with good nutrition or Vitamin A supplementation were
assumed to be the same for both groups.
 
5 Further work is being done at Johns Hopkins University to
include heterogeneity of risks and coverage levels.
6 The FORTRAN program for the model with the South Asian input
data is available from the first author.
